PNC-27 5mg
$250.00
PNC-27 is a peptide being studied in experimental Cancer research. Derived from a segment of the tumor-suppressor protein the p53 protein, it has attracted interest in laboratory studies as findings suggest the peptide may exhibit selective activity toward those cancer cells potentially disrupting the cancer cell membranes in laboratory models, which can lead to cell death in those experimental conditions.
PNC-27 is a peptide being studied in experimental oncology research. Derived from a segment of the tumor-suppressor protein the p53 protein, it has attracted interest in laboratory studies examining how certain peptides interact with proteins expressed on the surface of malignant cells. Current work focuses on molecular mechanisms and structure-activity relationships rather than clinical applications.
In preclinical research models, PNC-27 has been studied for its interaction with cancer-associated cell membrane targets, particularly HDM-2 proteins that can be present on the membranes of certain cancer cells. Some laboratory findings suggest the peptide may exhibit selective activity toward those cancer cells expressing this protein specifically potentially disrupting the cancer cell membranes in laboratory models, which can lead to cell death in those experimental conditions. The peptides seems to selectively act differently not interacting with normal cells under experimental conditions. These investigations remain limited to preclinical research environments.
